/* SEO STARTS */ ?> /* SEO ENDS */ ?>
Scranton, PA -
The Scranton Lackawanna Industrial Building Company (SLIBCO), The Greater Scranton Chamber of Commerce's industrial development affiliate, welcomes five new businesses to the TekRidge Center - a technology incubator office facility located at the Jessup Small Business Center in Jessup, Pennsylvania.
Business incubator programs are designed to support the successful development of entrepreneurial companies through an array of business resources and services. As part of The Greater Scranton Chamber of Commerce's efforts to promote business activity in the region, the TekRidge Center offers a number of services to start-up and expanding small business ventures in Northeastern Pennsylvania. The business incubator tenants at the facility have access to shared office services, a conference room, equipment, flexible leases, and expandable office space.
The TekRidge Center is situated within a Keystone Opportunity Expansion Zone offering tax benefits through 2020. The facility is also located in a Keystone Innovation Zone (KIZ), an incentive program that provides tax credits to for-profit companies less than eight years old operating within specific targeted industries.
A ceremony will be held to welcome the new businesses of the building on Friday, September 27, 2013 at 3:00pm.
The TekRidge Center welcomes the following new businesses:
Med-Dev Corporation
The Northeastern Pennsylvania Regional Bioscience Initiative (NEPA RBI) is focused on growing bioscience employment within our region. Med-Dev Corporation is a prime example of the type of business in the bioscience industry that can find success in NEPA. Med-Dev Corporation is a medical device development company comprised of an accomplished team of medical professionals and private business entrepreneurs. The company has acquired an exclusive license to patent pending technologies and corresponding Intellectual Property to develop, market and distribute a novel pro-active medical device called the M-Clip that utilizes a non-antibiotic patent pending formulation that has been found effective against MRSA nasal colonization.